This study aims to identify the risk factors for adverse events in dilated cardiomyopathy (DCM) patients with LVEF≥35% and establish a scoring model to predict adverse event risk. 269 consecutive DCM patients with LVEF ≥35% who underwent gadolinium-enhanced cardiac magnetic resonance (CMR) imaging were enrolled in this study. The primary endpoint was a composite of SCD or aborted SCD. Secondary endpoints were all-cause mortality, heart transplantation and hospitalization for heart failure. The nomogram we created using these parameters provides a novel way to clinically assess and risk stratify this patient population.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords